The Case Against Capsulectomies When Removing Silicone Breast Implants

Abstract

Requests for removal of silicone breast implants are increasingly common. Often patients request a capsulectomy in either a total or “en bloc” form. Capsulectomy adds time, cost, and morbidity to removal of implant procedures. This article examines the reasoning given by practitioners for undertaking the procedure, and reviews the literature to examine the validity of those arguments. Except where pathology of the capsule is demonstrable (Breast implant related anaplastic large cell lymphoma, BIR-ALCL), there is currently no indication for prophylactic removal of capsules following removal of breast implants. Given the potential risks, and lack of evidence for the procedure, both patient and surgeons should be aware of the potential consequences.

Keywords

breast augmentation capsulectomy breast implant removal

Get full access to this article

View all access options for this article.

References

Kaplan

Rohrich

. Breast implant illness: a topic in review. Gland Surg. 2021;10(1):430-443. doi:10.21037/gs-20-231.

Roth

Felder

Friedman

. Breast capsulectomy specimens and their clinical implications. Plast Reconstr Surg. 2010;126(6):1848-1852. doi:10.1097/PRS.0b013e3181f4463c.

Lapid

Noels

Meijer

. Pathologic findings in primary capsulectomy specimens: analysis of 2531 patients. Aesthet Surg J. 2014;34(5):714-718. doi:10.1177/1090820X14531144.

Thomson

. The fate of the pseudosheath pocket around silicone implants. Plast Reconstr Surg. 1973;51(6):667-671. doi:10.1097/00006534-197306000-00011.

Friedman

Carson

. The fate of the fibrous capsule after saline implant removal. Ann Plast Surg. 2001;46(3):215-221. doi:10.1097/00000637-200103000-00002.

Latorre

Marotta

Batich

Hardt

. In vitro measurement of silicone bleed from breast implants. Plast Reconstr Surg. 1996;97(4):756-764. doi:10.1097/00006534-199604000-00011.

Zambacos

Molnar

Mandrekas

. Silicone lymphadenopathy after breast augmentation: case reports, review of the literature, and current thoughts. Aesthetic Plast Surg. 2013;37(2):278-289. doi:10.1007/s00266-012-0025-9.

Institute of Medicine (US) Committee on the Safety of Silicone Breast Implants. Safety of Silicone Breast Implants. Bondurant

Ernster

Herdman

, eds. Washington, DC: National Academies Press (US); 1999.

Hausner

Schoen

Pierson

. Foreign-body reaction to silicone gel in axillary lymph nodes after an augmentation mammaplasty. Plast Reconstr Surg. 1978;62(3):381-384. doi:10.1097/00006534-197809000-00007.

10.

Austad

. Breast implant-related silicone granulomas: the literature and the litigation. Plast Reconstr Surg. 2002;109(5):1724-1730; discussion 1731-1732. doi:10.1097/00006534-200204150-00040.

11.

van Diest

Beekman

Hage

. Pathology of silicone leakage from breast implants. J Clin Pathol. 1998;51(7):493-497. doi:10.1136/jcp.51.7.493.

12.

Barnard

Todd

Wilson

Mielcarek

Rohrich

. Distribution of organosilicon polymers in augmentation mammaplasties at autopsy. Plast Reconstr Surg. 1997;100(1):197-203; discussion 204-205. doi:10.1097/00006534-199707000-00030

13.

Katzin

Centeno

Feng

Kiley

Mullick

. Pathology of lymph nodes from patients with breast implants: a histologic and spectroscopic evaluation. Am J Surg Pathol. 2005;29(4):506-511. doi:10.1097/01.pas.0000155145.60670.e4.

14.

Dijkman

HBPM

Slaats

Bult

. Assessment of silicone particle migration among women undergoing removal or revision of silicone breast implants in the Netherlands. JAMA Netw Open. 2021;4(9):e2125381. doi:10.1001/jamanetworkopen.2021.25381.

15.

The FDA Requests Allergan Voluntarily Recall Natrelle BIOCELL Textured Breast Implants and Tissue Expanders from the Market to Protect Patients: FDA Safety Communication. Accessed April 1, 2021. https://www.fda.gov/medical-devices/safety-communications/fda-requests-allergan-voluntarily-recall-natrelle-biocell-textured-breast-implants-and-tissue

16.

Clemens

McGuire

. Discussion: a prospective approach to inform and treat 1340 patients at risk for BIA-ALCL. Plast Reconstr Surg. 2019;144(1):57-59. doi:10.1097/PRS.0000000000005756.

17.

Clemens

Medeiros

Butler

, et al. Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma. J Clin Oncol. 2016;34(2):160-168. doi:10.1200/JCO.2015.63.3412.

18.

Calobrace

Mays

. An algorithm for the management of explantation surgery. Clin Plast Surg. 2021;48(1):1-16. doi:10.1016/j.cps.2020.09.005.

19.

Tanna

Calobrace

Clemens

, et al. Not all breast explants are equal: contemporary strategies in breast explantation surgery. Plast Reconstr Surg. 2021;147(4):808-818. doi:10.1097/PRS.0000000000007784.

20.

Clemens

. Commentary on: management of asymptomatic patients with textured breast implants: a survey analysis of members of the aesthetic society. Aesthet Surg J. 2021:sjab141. doi:10.1093/asj/sjab141.

21.

Clemens

. ALCL FAQ town hall. Presented at: Meeting of the American Society of Plastic Surgeons; San Diego, CA; September 2019.

22.

Rohrich

Kaplan

Dayan

. Silicone implant illness: science versus myth? Plast Reconstr Surg. 2019;144(1):98-109. doi:10.1097/PRS.0000000000005710.

23.

Mcguire

Haws

Nahai

. Breast implant illness: how can we help? Aesthet Surg J. 2019;39(11):1260-1263. doi:10.1093/asj/sjz227.

24.

Johal

Floyd

. To bloc or not to bloc: challenges in the management of patients requesting “en-bloc capsulectomy.” Aesthet Surg J. 2020;40(9):NP561-NP563. doi:10.1093/asj/sjaa115.

25.

Swanson

. The case for breast implant removal or replacement without capsulectomy. Aesthetic Plast Surg. 2021;45(3):1338-1341. doi:10.1007/s00266-020-02079-1.

26.

Lipworth

Tarone

McLaughlin

. Silicone breast implants and connective tissue disease: an updated review of the epidemiologic evidence. Ann Plast Surg. 2004;52(6):598-601. doi:10.1097/01.sap.0000128087.51384.f9.

27.

Gabriel

O’Fallon

Kurland

, et al. Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med. 1994;330(24):1697-1702. doi:10.1056/NEJM199406163302401.

28.

Sánchez-Guerrero

Colditz

Karlson

Hunter

Speizer

Liang

. Silicone breast implants and the risk of connective-tissue diseases and symptoms. N Engl J Med. 1995;332(25):1666-1670. doi:10.1056/NEJM199506223322502.

29.

Hölmich

Lipworth

McLaughlin

Friis

. Breast implant rupture and connective tissue disease: a review of the literature. Plast Reconstr Surg. 2007;120(7 suppl 1):62S-69S. doi: 10.1097/01.prs.0000286664.50274.f2.

30.

Hölmich

Friis

Fryzek

, et al. Incidence of silicone breast implant rupture. Arch Surg. 2003;138(7):801-816. doi:10.1001/archsurg.138.7.801.

31.

Fryzek

Holmich

McLaughlin

, et al. A nationwide study of connective tissue disease and other rheumatic conditions among Danish women with long-term cosmetic breast implantation. Ann Epidemiol. 2007;17(5):374-379. doi:10.1016/j.annepidem.2006.11.001.

32.

Young

. Guidelines and indications for breast implant capsulectomy. Plast Reconstr Surg. 1998;102(3):884-891; discussion 892.

33.

Swanson

. Open capsulotomy: an effective but overlooked treatment for capsular contracture after breast augmentation. Plast Reconstr Surg Glob Open. 2016;4(10):e1096. doi:10.1097/GOX.0000000000001096.

34.

Gascoigne

Malata

. Pleural damage during capsulectomy and exchange of long-standing breast implants in Poland syndrome: a cautionary tale. Ann Plast Surg. 2012;69(2):148-151. doi:10.1097/SAP.0b013e318226b4c4.

35.

Lee

Jin

Lee

. Subpectoral and precapsular implant repositioning technique: correction of capsular contracture and implant malposition. Aesthetic Plast Surg. 2011;35:1126-1132. doi:10.1007/s00266-011-9714-z.

36.

Keane

Chi

Myckatyn

. En Bloc Capsulectomy for breast implant illness: a social media phenomenon? Aesthet Surg J. 2021;41(4):448-459. doi:10.1093/asj/sjaa203.

37.

Becker

. Capsulectomy—medically or legally indicated? Plast Reconstr Surg. 1992;90(4):731. doi:10.1097/00006534-199210000-00046.